The latter, TRβ2–46, functions as an oncogenic TH receptor isoform that drives the expression of kinase-associated protein 2 (SKP2), an E3 ubiquitin ligase that facilitates cell cycle progression, promoting retinoblastoma cell proliferation in an RB1-deficient background [312]. Here, SKP2 is linked to retinoblastoma.